Internal Medicine Doctors in Glenwood, MD Accepting Medicare
1 Internal Medicine doctors found. Showing 1 - 1
 Scott T Maurer, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2465 State Route 97, Suite 10, Glenwood, MD 21738 Phone: 410-489-9550 Fax: 410-489-5527 |
News Archive
Financial exploitation of the elderly is on the rise, shows research
Researchers at Wayne State University, in collaboration with Illinois Institute of Technology, recently published a study advising clinical gerontologists in the field to be aware of older adults' needs for assessment of financial exploitation or its potential when working with highly vulnerable individuals.
Findings about diabetic eye disease may lead to improved screenings and treatment for people with diabetes
Eli Lilly and Company have announced key findings from analyses of prior study data that enhances understanding of vision loss due to diabetic retinopathy, a diabetic microvascular complication that affects an estimated 50 million people worldwide.
Achillion nominates ACH-2928 NS5A clinical candidate for treatment of HCV
Achillion Pharmaceuticals, Inc., a leader in the discovery and development of treatments for the most challenging infectious diseases, today announced the nomination of a lead clinical candidate in its fourth proprietary program against hepatitis C virus (HCV) infection. The candidate, ACH-2928, is an NS5A inhibitor that in preclinical studies has demonstrated excellent potency against HCV RNA replication, as well as good pharmacokinetic and safety profiles.
Sunbeds ARE bad for your health
The sunbed industry is ignoring warnings by the World Health Organisation and Cancer Research UK about sunbed use despite the incidence of skin cancer doubling in the last ten years, says Which? today (5.6.04).
PAREXEL genotypes over 10,000 potential study participants to identify 400 CYP2D6 poor metabolizers
PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced that it has completed a large and complex pharmacogenetics-based early phase study. The study was conducted in a healthy volunteer population of poor metabolizers of Cytochrome P450 2D6 (CYP2D6), an important enzyme involved in the metabolism of drugs. The study monitored the QTc interval following administration of a neurological treatment, which has been shown to have a higher drug exposure in poor metabolizers of CYP2D6.
› Verified 3 days ago